MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

20 Feb 2019 Evaluate

With reference to the subject ‘Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris, an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting’, Glenmark Pharmaceuticals has informed about submission of media release which is self explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..